Header Logo

Connection

Jie Wu to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications Jie Wu has written about Carcinoma, Non-Small-Cell Lung.
Jie Wu
Connection Strength
0.629
Carcinoma, Non-Small-Cell Lung
  1. Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations. Ann Oncol. 2021 02; 32(2):261-268.
    View in: PubMed
    Score: 0.629
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.